Treatment of mucosa associated lymphoid tissue lymphoma with a long‐term once‐weekly regimen of oral azithromycin: Results from the phase II MALT—A trial

The macrolide clarithromycin has been reported as active for therapy of mucosa associated lymphoid tissue (MALT) lymphoma. Pharmacokinetic properties, however, require continuous daily intake over a prolonged period of time. As the macrolide azithromycin is characterized by a long half‐life as well...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hematol Oncol
Autori principali: Lagler, Heimo, Kiesewetter, Barbara, Dolak, Werner, Obermueller, Markus, Simonitsch‐Klupp, Ingrid, Lukas, Julius, Neuper, Ortrun, Lamm, Wolfgang W., Mayerhoefer, Marius E., Raderer, Markus
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6585850/
https://ncbi.nlm.nih.gov/pubmed/30153341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2555
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi